Literature DB >> 7705889

Effects of interleukin-6 (IL-6) and transforming growth factor-beta (TGF-beta) on neutrophil elastase release.

U Bank1, D Reinhold, D Kunz, H U Schulz, C Schneemilch, W Brandt, S Ansorge.   

Abstract

The proinflammatory cytokine interleukin-6 (IL-6) and its potential opponent, transforming growth factor-beta (TGF-beta 1), have been discussed as being involved in the regulation of inflammatory processes following trauma and infections. The aim of this study was to investigate the effect of these cytokines on the regulation of neutrophil degranulation. The posttraumatic time courses of the plasma concentrations of IL-6, and the elastase-alpha 1-proteinase-inhibitor complex as marker of degranulation in patients undergoing severe trauma were found to be highly correlated, whereas TGF-beta 1 levels were determined to be not significantly altered. The close temporal correlation of IL-6 and elastase levels could be confirmed by investigation of exudates derived from the surgical area. To prove these in vivo findings, the effect of IL-6 and TGF-beta 1 on the degranulation of isolated neutrophils of healthy donors was investigated in vitro. Pathological high IL-6 concentrations were found to be capable of inducing a significant release of lysosomal elastase in a concentration-dependent manner, whereas the degranulation was unaffected by TGF-beta 1. In conclusion, these data suggest an involvement of IL-6 in the regulation of neutrophil degranulation under pathological conditions. However, TGF-beta 1 seems to have no direct regulatory effects besides its described chemotactic function on neutrophils.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7705889     DOI: 10.1007/bf01534383

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  42 in total

1.  Degradation of cartilage matrix proteoglycan by human neutrophils involves both elastase and cathepsin G.

Authors:  M J Janusz; N S Doherty
Journal:  J Immunol       Date:  1991-06-01       Impact factor: 5.422

2.  Cathepsin-G and leukocyte elastase inactivate human tumor necrosis factor and lymphotoxin.

Authors:  P Scuderi; P A Nez; M L Duerr; B J Wong; C M Valdez
Journal:  Cell Immunol       Date:  1991-07       Impact factor: 4.868

Review 3.  Poly's lament: the neglected role of the polymorphonuclear neutrophil in the afferent limb of the immune response.

Authors:  A R Lloyd; J J Oppenheim
Journal:  Immunol Today       Date:  1992-05

Review 4.  Cytokines: from clone to clinic.

Authors:  B B Aggarwal; E Pocsik
Journal:  Arch Biochem Biophys       Date:  1992-02-01       Impact factor: 4.013

5.  Stimulation and priming of human neutrophils by interleukin-8: cooperation with tumor necrosis factor and colony-stimulating factors.

Authors:  A Yuo; S Kitagawa; T Kasahara; K Matsushima; M Saito; F Takaku
Journal:  Blood       Date:  1991-11-15       Impact factor: 22.113

Review 6.  Activation of the oxidative metabolism in human polymorphonuclear neutrophilic granulocytes: the role of immuno-modulating cytokines.

Authors:  A Kapp; G Zeck-Kapp
Journal:  J Invest Dermatol       Date:  1990-12       Impact factor: 8.551

7.  Neutrophil responses to lipopolysaccharide. Effect of adherence on triggering and priming of the respiratory burst.

Authors:  Y Aida; M J Pabst
Journal:  J Immunol       Date:  1991-02-15       Impact factor: 5.422

8.  Type I transforming growth factor-beta receptors on neutrophils mediate chemotaxis to transforming growth factor-beta.

Authors:  M E Brandes; U E Mai; K Ohura; S M Wahl
Journal:  J Immunol       Date:  1991-09-01       Impact factor: 5.422

9.  Inhibitory effects of interleukin 6 on immunity. Possible implications in burn patients.

Authors:  D H Zhou; A M Munster; R A Winchurch
Journal:  Arch Surg       Date:  1992-01

10.  Plasma elastase alpha 1-antitrypsin and lactoferrin in sepsis: evidence for neutrophils as mediators in fatal sepsis.

Authors:  J H Nuijens; J J Abbink; Y T Wachtfogel; R W Colman; A J Eerenberg; D Dors; A J Kamp; R J Strack van Schijndel; L G Thijs; C E Hack
Journal:  J Lab Clin Med       Date:  1992-02
View more
  6 in total

1.  Granulocyte elastase release and pulmonary hemodynamics in patients with mitral valvular disease.

Authors:  Hidenori Gohra; Akihito Mikamo; Haruhiko Okada; Kimikazu Hamano; Nobuya Zempo; Kensuke Esato
Journal:  World J Surg       Date:  2002-04-15       Impact factor: 3.352

2.  IL-17-induced cytokine release in human bronchial epithelial cells in vitro: role of mitogen-activated protein (MAP) kinases.

Authors:  M Laan; J Lötvall; K F Chung; A Lindén
Journal:  Br J Pharmacol       Date:  2001-05       Impact factor: 8.739

3.  Innate immunity genes influence the severity of acute appendicitis.

Authors:  Fernando A Rivera-Chavez; Dixie L Peters-Hybki; Robert C Barber; Guy M Lindberg; Ishwarlal Jialal; Robert S Munford; Grant E O'Keefe
Journal:  Ann Surg       Date:  2004-08       Impact factor: 12.969

Review 4.  The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease.

Authors:  B Afzali; G Lombardi; R I Lechler; G M Lord
Journal:  Clin Exp Immunol       Date:  2007-04       Impact factor: 4.330

5.  CD45+CD33lowCD11bdim myeloid-derived suppressor cells suppress CD8+ T cell activity via the IL-6/IL-8-arginase I axis in human gastric cancer.

Authors:  Fang-Yuan Mao; Yong-Liang Zhao; Yi-Pin Lv; Yong-Sheng Teng; Hui Kong; Yu-Gang Liu; Xiao-Long Wu; Chuan-Jie Hao; Weisan Chen; Mu-Bing Duan; Bin Han; Qiang Ma; Ting-Ting Wang; Liu-Sheng Peng; Jin-Yu Zhang; Ping Cheng; Chong-Yu Su; Xiao-Long Fu; Quan-Ming Zou; Gang Guo; Xiao-Lan Guo; Yuan Zhuang
Journal:  Cell Death Dis       Date:  2018-07-09       Impact factor: 8.469

Review 6.  The Immunoregulation of Th17 in Host against Intracellular Bacterial Infection.

Authors:  Yonghong Li; Chaojun Wei; Hui Xu; Jing Jia; Zhenhong Wei; Rui Guo; Yanjuan Jia; Yu Wu; Yuanting Li; Xiaoming Qi; Zhenhao Li; Xiaoling Gao
Journal:  Mediators Inflamm       Date:  2018-03-19       Impact factor: 4.711

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.